BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Treatment
2580 results:

  • 1. Correlation between changes in nutritional status and tumor response in patients receiving immunotherapy for lung cancer (NUTIMMUNO study).
    Mahé M; Seegers V; Vansteene D
    Support Care Cancer; 2024 Apr; 32(5):312. PubMed ID: 38676729
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Non-small cell lung cancer and immune checkpoint inhibitor therapy: does non-alcoholic fatty liver disease have an effect?
    Li Y; Gong B; Guo Y; Liu W; Chen C; Jiang S; Pan F; Song J; Yang L; Zhou G
    BMC Cancer; 2024 Apr; 24(1):535. PubMed ID: 38671373
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Tumor-agnostic transcriptome-based classifier identifies spatial infiltration patterns of CD8+T cells in the tumor microenvironment and predicts clinical outcome in early-phase and late-phase clinical trials.
    Roller A; Davydov II; Schwalie PC; Serrano-Serrano ML; Heller A; Staedler N; Ferreira CS; Dietmann G; Klaman I; Valdeolivas A; Korski K; Cannarile MA
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38649280
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [cancer survival analysis in Tianjin, 2010 to 2016].
    Wang C; Shen CF; Xun LN; Zhang S; Zhang H; Zheng WL; Wang DZ
    Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):319-325. PubMed ID: 38644267
    [No Abstract]    [Full Text] [Related]  

  • 5. [Long-term outcome of patients with rectal cancer who achieve complete or near complete clinical responses after neoadjuvant therapy: a multicenter registry study of data from the Chinese Watch and Wait Database].
    Zhao YM; Wang WH; Zhang W; Wang L; Li S; Wang JW; Liao LE; Yu GY; Sun Z; Qu YL; Gong Y; Lu Y; Wu T; Li YF; Wang Q; Zhao GH; Xiao Y; Ding PR; Zhang Z; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):372-382. PubMed ID: 38644243
    [No Abstract]    [Full Text] [Related]  

  • 6. Association of the Advanced lung cancer Inflammation Index (ALI) and Gustave Roussy Immune (GRIm) score with immune checkpoint inhibitor efficacy in patients with gastrointestinal and lung cancer.
    Jiang H; Li B; Wu M; Wang Q; Li Y
    BMC Cancer; 2024 Apr; 24(1):428. PubMed ID: 38589844
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.
    Zhang L; Xiong Y; Zhang J; Feng Y; Xu A
    J Transl Med; 2024 Apr; 22(1):330. PubMed ID: 38576019
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comprehensive analysis and validation reveal DEPDC1 as a potential diagnostic biomarker associated with tumor immunity in non-small-cell lung cancer.
    Lv M; Li X; Yin Z; Yang H; Zhou B
    PLoS One; 2024; 19(4):e0294227. PubMed ID: 38564630
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The Role of Pharmaceutical Innovation in Clinical Practice Guidelines for Chronic Diseases.
    Roach M; Land N; Hernandez J; Rau R; Chou JW; Hickson SS; Rollmann DF; Maclean JR
    Int J Clin Pract; 2024; 2024():5877687. PubMed ID: 38505696
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Multicenter evaluation of an automated, multiplex, RNA-based molecular assay for detection of ALK, ROS1, RET fusions and MET exon 14 skipping in NSCLC.
    Melchior L; Hirschmann A; Hofman P; Bontoux C; Concha A; Mrabet-Dahbi S; Vannuffel P; Watkin E; Putzová M; Scarpino S; Cayre A; Martin P; Stoehr R; Hartmann A
    Virchows Arch; 2024 Apr; 484(4):677-686. PubMed ID: 38492039
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Feasibility of precision smoking treatment in a low-income community setting: results of a pilot randomized controlled trial in The Southern Community Cohort Study.
    Lee SS; Senft Everson N; Sanderson M; Selove R; Blot WJ; King S; Gilliam K; Kundu S; Steinwandel M; Sternlieb SJ; Cai Q; Warren Andersen S; Friedman DL; Connors Kelly E; Fadden MK; Freiberg MS; Wells QS; Canedo J; Tyndale RF; Young RP; Hopkins RJ; Tindle HA
    Addict Sci Clin Pract; 2024 Mar; 19(1):16. PubMed ID: 38491559
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Adjuvant treatment with Cordyceps sinensis for lung cancer: A systematic review and meta-analysis of randomized controlled trials.
    Wang C; Wang J; Qi Y
    J Ethnopharmacol; 2024 Jun; 327():118044. PubMed ID: 38484953
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Value of next generation sequencing (NGS) testing in advanced cancer patients.
    Ortendahl JD; Cuyun Carter G; Thakkar SG; Bognar K; Hall DW; Abdou Y
    J Med Econ; 2024; 27(1):519-530. PubMed ID: 38466204
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Association of Timely Comprehensive Genomic Profiling With Precision Oncology treatment Use and Patient Outcomes in Advanced Non-Small-Cell lung cancer.
    Yorio J; Lofgren KT; Lee JK; Tolba K; Oxnard GR; Schrock AB; Huang RSP; Brisbin L
    JCO Precis Oncol; 2024 Mar; 8():e2300292. PubMed ID: 38452312
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non-Small Cell lung cancer.
    Tsukita Y; Tozuka T; Kushiro K; Hosokawa S; Sumi T; Uematsu M; Honjo O; Yamaguchi O; Asao T; Sugisaka J; Saito G; Shiihara J; Morita R; Katakura S; Yasuda T; Hisakane K; Miyauchi E; Morita S; Kobayashi K; Asahina H
    JAMA Oncol; 2024 Apr; 10(4):439-447. PubMed ID: 38451530
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Stereotactic ablative brachytherapy versus percutaneous microwave ablation for early-stage non-small cell lung cancer: a multicenter retrospective study.
    Wu C; Cao B; He G; Li Y; Wang W
    BMC Cancer; 2024 Mar; 24(1):304. PubMed ID: 38448897
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. SALTT study: A retrospective analysis of 111 SAlivary gland tumors of lung and Tracheobronchial Tree.
    Batra N; Mishra P; Pai T; Jiwnani S; Karimundackal G; Tiwari V; Purandare N; Janu A; Noronha V; Joshi A; Prabhash K; Tibdewal A; Agarwal JP; Pramesh CS; Kaushal RK
    Ann Diagn Pathol; 2024 Jun; 70():152283. PubMed ID: 38447254
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients.
    Pasello G; Fabricio ASC; Del Bianco P; Salizzato V; Favaretto A; Piccin L; Zustovich F; Fabozzi A; De Rossi C; Pigozzo J; De Nuzzo M; Cappelletto E; Bonanno L; Palleschi D; De Salvo GL; Guarneri V; Gion M; Chiarion-Sileni V
    J Transl Med; 2024 Mar; 22(1):242. PubMed ID: 38443899
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Body mass index, weight change, and cancer prognosis: a meta-analysis and systematic review of 73 cohort studies.
    Wen H; Deng G; Shi X; Liu Z; Lin A; Cheng Q; Zhang J; Luo P
    ESMO Open; 2024 Mar; 9(3):102241. PubMed ID: 38442453
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The Danish lung cancer registry: A nationwide validation study.
    Gouliaev A; Ali F; Jakobsen E; Dalton SO; Hilberg O; Rasmussen TR; Christensen NL
    Lung Cancer; 2024 Apr; 190():107527. PubMed ID: 38432026
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 129.